Literature DB >> 16249654

Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil.

Palmira de F Bonolo1, Cibele C César, Francisco A Acúrcio, Maria das Graças B Ceccato, Cristiane A Menezes de Pádua, Juliana Alvares, Lorenza N Campos, Ricardo A Carmo, Mark D C Guimarães.   

Abstract

OBJECTIVE: To assess the incidence, magnitude and factors associated with the first episode of non-adherence for 12 months after the first antiretroviral prescription.
DESIGN: A prospective study of HIV-infected patients receiving their first antiretroviral prescription in public referral centers, Belo Horizonte, Brazil. Baseline assessment occurred at the moment of the first prescription and follow-up visits at the first, fourth and seventh month, from May 2001 to May 2003.
METHODS: Non-adherence was self-reported and defined as the intake of less than 95% of the prescribed doses for 3 days before the follow-up interviews. Cumulative and person-time incidence were estimated and Cox's proportional model was used to assess the relative hazard (RH) of non-adherence with 95% confidence interval for both univariate and multivariate analysis.
RESULTS: Among 306 patients, the cumulative incidence of non-adherence was 36.9% (incidence rate 0.21/100 person-days). Multivariate analysis (P < 0.05) showed that unemployment (RH = 2.17), alcohol use (RH = 2.27), self-report of three or more adverse reactions (RH = 1.64), number of pills per day (RH = 2.04), switch in antiretroviral regimen (RH = 2.72), and a longer time between the HIV test result and the first antiretroviral prescription (RH = 2.27) were associated with an increased risk of non-adherence, whereas the use of more than one health service indicated a negative association (RH = 0.54).
CONCLUSION: The current analysis has pointed out the importance of clinical and health service characteristics as potential indicators of non-adherence after initiating therapy. Early assessment and intervention strategies should be priorities in these AIDS public referral centres. Feasible and reliable indicators for the routine monitoring of adherence should be incorporated in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249654     DOI: 10.1097/01.aids.0000191484.84661.2b

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  31 in total

1.  Individual and treatment setting predictors of HIV/AIDS knowledge among psychiatric patients and their implications in a national multisite study in Brazil.

Authors:  Ana Paula Souto Melo; Cibele Comini César; Francisco de Assis Acurcio; Lorenza Nogueira Campos; Maria das Graças Braga Ceccato; Milton L Wainberg; Karen McKinnon; Mark Drew Crosland Guimarães
Journal:  Community Ment Health J       Date:  2010-03-30

2.  Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.

Authors:  Michael Hoffmann; Sarah MacCarthy; Ashley Batson; Ann Crawford-Roberts; Jennifer Rasanathan; Amy Nunn; Luis Augusto Silva; Ines Dourado
Journal:  AIDS Care       Date:  2015-08-20

Review 3.  Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.

Authors:  Cathy M Puskas; Jamie I Forrest; Surita Parashar; Kate A Salters; Angela M Cescon; Angela Kaida; Cari L Miller; David R Bangsberg; Robert S Hogg
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

Review 4.  Alcohol use and antiretroviral adherence: review and meta-analysis.

Authors:  Christian S Hendershot; Susan A Stoner; David W Pantalone; Jane M Simoni
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

5.  A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

Authors:  Charles P Brandt; Daniel J Paulus; Monica Garza; Chad Lemaire; Peter J Norton; Michael J Zvolensky
Journal:  Cogn Behav Pract       Date:  2017-03-02

6.  The relationship between adherence to clinic appointments and year-one mortality for newly enrolled HIV infected patients at a regional referral hospital in Western Kenya, January 2011-December 2012.

Authors:  Muthusi Kimeu; Barbara Burmen; Beryl Audi; Anne Adega; Karen Owuor; Susan Arodi; Dennis Bii; Emily Zielinski-Gutiérrez
Journal:  AIDS Care       Date:  2015-11-17

7.  Magnitude and determinants of nonadherence and nonreadiness to highly active antiretroviral therapy among people living with HIV/AIDS in Northwest Ethiopia: a cross-sectional study.

Authors:  Belay Tessema; Fantahun Biadglegne; Andargachew Mulu; Assefa Getachew; Frank Emmrich; Ulrich Sack
Journal:  AIDS Res Ther       Date:  2010-01-14       Impact factor: 2.250

8.  Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia.

Authors:  Ayele Tiyou; Tefera Belachew; Fisehaye Alemseged; Sibhatu Biadgilign
Journal:  AIDS Res Ther       Date:  2010-10-30       Impact factor: 2.250

9.  Quality of life among HIV-infected patients in Brazil after initiation of treatment.

Authors:  Lorenza Nogueira Campos; Cibele Comini César; Mark Drew Crosland Guimarães
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Difficulties reported by HIV-infected patients using antiretroviral therapy in Brazil.

Authors:  Mark Drew Crosland Guimarães; Gustavo Machado Rocha; Lorenza Nogueira Campos; Felipe Melo Teixeira de Freitas; Felipe Augusto Souza Gualberto; Ramiro d' Avila Rivelli Teixeira; Fábio Morato de Castilho
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.